Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue
Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous da...
Saved in:
Published in | Retrovirology Vol. 9; no. 1; p. 20 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
15.03.2012
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications.
Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity.
Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. |
---|---|
AbstractList | Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. BACKGROUNDTransmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. RESULTSAlmost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. CONCLUSIONSOur study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. Doc number: 20 Abstract Background: Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results: Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions: Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue. |
ArticleNumber | 20 |
Audience | Academic |
Author | Simmonds, Peter Bell, Jeanne Gonzalez-Perez, Maria Paz O'Connell, Olivia Sullivan, W Matthew Lin, Rongheng Clapham, Paul R |
AuthorAffiliation | 4 Centre for Infectious Diseases, Summerhall, Edinburgh EH9 1QH, UK 2 School of Public Health and Health Sciences, University of Massachusetts, 411 Arnold House, 715 North Pleasant Street, Amherst, MA 01003-9304 3 The MRC HIV brain and tissue bank in Edinburgh, Department of Pathology (Neuropathology), University of Edinburgh, Wilkie Building, Teviot Place, Edinburgh, UK EH8 9AG 1 Program in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, Massachusetts 01605-2377 |
AuthorAffiliation_xml | – name: 3 The MRC HIV brain and tissue bank in Edinburgh, Department of Pathology (Neuropathology), University of Edinburgh, Wilkie Building, Teviot Place, Edinburgh, UK EH8 9AG – name: 2 School of Public Health and Health Sciences, University of Massachusetts, 411 Arnold House, 715 North Pleasant Street, Amherst, MA 01003-9304 – name: 1 Program in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, Massachusetts 01605-2377 – name: 4 Centre for Infectious Diseases, Summerhall, Edinburgh EH9 1QH, UK |
Author_xml | – sequence: 1 givenname: Maria Paz surname: Gonzalez-Perez fullname: Gonzalez-Perez, Maria Paz organization: Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts 01605-2377, USA – sequence: 2 givenname: Olivia surname: O'Connell fullname: O'Connell, Olivia – sequence: 3 givenname: Rongheng surname: Lin fullname: Lin, Rongheng – sequence: 4 givenname: W Matthew surname: Sullivan fullname: Sullivan, W Matthew – sequence: 5 givenname: Jeanne surname: Bell fullname: Bell, Jeanne – sequence: 6 givenname: Peter surname: Simmonds fullname: Simmonds, Peter – sequence: 7 givenname: Paul R surname: Clapham fullname: Clapham, Paul R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22420378$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks-L1DAUx4usuD_06lECXrx0za-26UUYFnUHFgRRryFNXmYytMmYtLN48W833VnHHV0JJI9vvvkk7-WdFyc-eCiKlwRfEiLqt6ThtOR1i8u2pPhJcXYQTh7Ep8V5ShuMGRFYPCtOKeUUs0acFT-X3sAW8uRHBLvQT6MLHgWLBqVj2K7VCsoxBy4NSHmDnNcRVAKD9FrFFaAOxlsAj66X30qCPlcI_A76sIWEthHSzHUedVHl-Q4wDJMHNLqUJnhePLWqT_Difr0ovn54_-Xqurz59HF5tbgpuxq3YylMxS1pDeMNUcYwSzqrsmBxazVjkE3CcM1bbCra1VZkuWoAN0YT3tmaXRTLPdcEtZHb6AYVf8ignLwTQlxJFUene5BaWFHhuhWVVtx2osUdFcCI4g1QZnBmvduztlM3gNE5w6j6I-jxjndruQo7yVhNm5pkwGIP6Fz4D-B4R4dBzn8p57-UraTzI97cPyKG7xOkUQ4uaeh75SFMSRJMBOMs-7P19V_WTZiiz-WeXU3NmOD0j2ulchGctyFfrWeoXNCW0LZitciuy0dceRgYnM6taV3WHzuQmymlCPaQJsFy7uB_E3v1sLoH---WZb8A1-3t-A |
CitedBy_id | crossref_primary_10_1097_COH_0b013e32835fc601 crossref_primary_10_1007_s11481_015_9644_7 crossref_primary_10_1371_journal_ppat_1011974 crossref_primary_10_1371_journal_ppat_1007432 crossref_primary_10_1007_s13365_017_0586_0 crossref_primary_10_1128_JVI_01834_12 crossref_primary_10_1128_JVI_00946_15 crossref_primary_10_1093_icb_icab034 crossref_primary_10_1189_jlb_0713368 crossref_primary_10_3389_fcimb_2020_00261 crossref_primary_10_1128_JVI_00755_17 crossref_primary_10_1007_s11910_013_0387_7 crossref_primary_10_1186_s12977_015_0141_0 crossref_primary_10_1007_s13365_014_0291_1 crossref_primary_10_1016_j_immuni_2014_08_014 crossref_primary_10_1073_pnas_1917034117 crossref_primary_10_1128_JVI_00841_17 crossref_primary_10_1186_1742_4690_9_82 crossref_primary_10_1371_journal_ppat_1010335 crossref_primary_10_1007_s13365_018_0633_5 crossref_primary_10_1007_s13365_024_01207_w crossref_primary_10_1007_s00705_018_4094_1 crossref_primary_10_1189_jlb_0612308 crossref_primary_10_1097_QAD_0000000000002616 crossref_primary_10_1371_journal_ppat_1005988 crossref_primary_10_1097_QAD_0b013e3283639804 crossref_primary_10_1128_JVI_01202_21 crossref_primary_10_1084_jem_20161190 crossref_primary_10_1002_9780471729259_mc15j01s28 crossref_primary_10_1186_s12977_015_0176_2 crossref_primary_10_1016_j_jviromet_2016_07_019 crossref_primary_10_3390_v15030590 |
Cites_doi | 10.1128/JVI.76.12.6277-6292.2002 10.1089/aid.2005.21.706 10.3109/13550289609146909 10.1186/1742-4690-6-69 10.1128/JVI.75.21.10073-10089.2001 10.1099/0022-1317-83-8-1809 10.1128/JVI.02328-05 10.1089/aid.2010.0359 10.1212/WNL.42.9.1736 10.1212/WNL.44.3_Part_1.474 10.1038/sj.cdd.4401623 10.1001/archneurol.2010.84 10.1016/j.virol.2006.09.036 10.1128/JVI.02187-10 10.1097/00002030-199509000-00004 10.1016/S0960-5428(06)80268-8 10.1016/j.virol.2005.04.034 10.3109/13550280009091950 10.1016/S0140-6736(89)92628-7 10.1002/ana.20304 10.1002/(SICI)1097-0258(20000215)19:3<389::AID-SIM326>3.0.CO;2-J 10.1093/nar/25.24.4876 10.1016/j.virol.2008.06.014 10.1080/135502801753248114 10.1128/JVI.00131-11 10.1038/35073667 10.1128/JVI.79.8.5203-5210.2005 10.1128/JVI.78.21.11807-11815.2004 10.1128/JVI.02585-07 10.1089/aid.1998.14.25 10.1089/088922202753519133 10.1128/JVI.02133-08 10.2217/fvl.10.34 10.1038/nm1197-1259 10.1128/jvi.71.4.2928-2933.1997 10.1089/vim.1991.4.123 10.1128/AAC.46.6.1896-1905.2002 10.18637/jss.v012.i05 10.1016/j.virol.2007.05.029 10.1371/journal.ppat.1002286 10.1128/JVI.76.8.4138-4144.2002 10.1007/s11904-010-0042-8 10.1038/nri1527 10.1099/vir.0.81111-0 10.1128/JVI.73.12.9741-9755.1999 10.1128/JVI.05170-11 10.1212/WNL.44.3_Part_1.481 10.1084/jem.20070567 10.1016/S0140-6736(96)10178-1 10.1002/ana.410380510 10.1186/1742-4690-5-5 10.1089/aid.2010.0177 10.1128/JVI.02068-09 10.1080/13550280390218706 10.1084/jem.20090378 10.1111/j.1750-3639.2002.tb00461.x 10.1186/1742-4690-8-67 10.1006/viro.1998.9141 10.1016/j.virol.2010.05.006 10.1089/aid.2008.0009 10.1093/hmg/8.10.1939 10.1016/S0002-9440(10)63767-4 10.1007/s004010051113 10.1097/00005072-199409000-00012 10.1128/JVI.79.17.11343-11352.2005 10.1073/pnas.0605513103 10.1016/0167-5699(95)80022-0 10.1093/infdis/168.4.818 10.1128/JVI.72.4.2855-2864.1998 10.1089/vim.2005.18.190 10.1128/JVI.78.18.10133-10148.2004 10.1073/pnas.0802203105 10.1016/S0140-6736(86)90169-8 10.1128/jvi.71.3.2059-2071.1997 10.1128/JVI.74.21.10074-10080.2000 10.1016/S0140-6736(94)91222-X 10.1084/jem.193.8.905 10.1093/molbev/msr121 10.1128/JVI.72.1.488-496.1998 10.1128/jvi.68.7.4400-4408.1994 10.1128/JVI.78.13.6915-6926.2004 10.1002/ana.410390606 10.1126/science.287.5453.602 10.1128/JVI.00296-09 10.1128/JVI.02006-06 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2012 BioMed Central Ltd. 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/1742-4690-9-20 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Virology and AIDS Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1742-4690 |
EndPage | 20 |
ExternalDocumentID | oai_doaj_org_article_c8f8506985ca4fb890b28e31a47e23d0 oai_biomedcentral_com_1742_4690_9_20 2672841041 A291295368 10_1186_1742_4690_9_20 22420378 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | Edinburgh Scotland |
GeographicLocations_xml | – name: Edinburgh Scotland |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: R24 NS45491 – fundername: NICHD NIH HHS grantid: R01 HD049273 – fundername: NIAID NIH HHS grantid: P01 AI082274 – fundername: NIAID NIH HHS grantid: R01 AI089334 – fundername: NIMH NIH HHS grantid: R24MH59724 – fundername: NIMH NIH HHS grantid: R24MH59745 – fundername: NIMH NIH HHS grantid: U01MH083506 – fundername: NIMH NIH HHS grantid: R01 MH64408 – fundername: NIAID NIH HHS grantid: P30-AI42845 – fundername: Wellcome Trust grantid: 095831 |
GroupedDBID | --- -A0 0R~ 123 29P 2VQ 2WC 3V. 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX AFPKN CITATION ABVAZ AFGXO AFNRJ 7U9 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-b609t-8d54f19d3471add3f1bfaf19f09fc33e6098d4c490d52b6f89fc57e07dc14bf63 |
IEDL.DBID | RPM |
ISSN | 1742-4690 |
IngestDate | Fri Oct 04 13:00:59 EDT 2024 Tue Sep 17 20:47:58 EDT 2024 Wed May 22 07:15:44 EDT 2024 Tue Aug 27 04:52:50 EDT 2024 Thu Oct 10 17:33:49 EDT 2024 Thu Feb 22 23:24:33 EST 2024 Fri Feb 02 04:07:25 EST 2024 Thu Sep 12 18:37:32 EDT 2024 Wed Oct 16 01:00:07 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b609t-8d54f19d3471add3f1bfaf19f09fc33e6098d4c490d52b6f89fc57e07dc14bf63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362761/ |
PMID | 22420378 |
PQID | 1017633842 |
PQPubID | 54665 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c8f8506985ca4fb890b28e31a47e23d0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3362761 biomedcentral_primary_oai_biomedcentral_com_1742_4690_9_20 proquest_miscellaneous_1018343690 proquest_journals_1017633842 gale_infotracmisc_A291295368 gale_infotracacademiconefile_A291295368 crossref_primary_10_1186_1742_4690_9_20 pubmed_primary_22420378 |
PublicationCentury | 2000 |
PublicationDate | 2012-03-15 |
PublicationDateYYYYMMDD | 2012-03-15 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Retrovirology |
PublicationTitleAlternate | Retrovirology |
PublicationYear | 2012 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 10649304 - Stat Med. 2000 Feb 15;19(3):389-404 17182681 - J Virol. 2007 Mar;81(5):2359-71 21159865 - J Virol. 2011 Mar;85(5):2397-405 8376829 - J Infect Dis. 1993 Oct;168(4):818-24 11175322 - J Neurovirol. 2000 Dec;6(6):498-506 15630430 - Nat Rev Immunol. 2005 Jan;5(1):69-81 15479822 - J Virol. 2004 Nov;78(21):11807-15 21843318 - Retrovirology. 2011;8:67 12408230 - Brain Pathol. 2002 Oct;12(4):442-55 7874396 - Adv Neuroimmunol. 1994;4(3):283-5 21226626 - AIDS Res Hum Retroviruses. 2011 Aug;27(8):889-901 19487424 - J Exp Med. 2009 Jun 8;206(6):1273-89 21546353 - Mol Biol Evol. 2011 Oct;28(10):2731-9 10871768 - J Neurovirol. 2000 May;6 Suppl 1:S70-81 19129457 - J Virol. 2009 Mar;83(6):2575-83 7515972 - J Virol. 1994 Jul;68(7):4400-8 11581376 - J Virol. 2001 Nov;75(21):10073-89 18788913 - AIDS Res Hum Retroviruses. 2008 Sep;24(9):1215-20 10559284 - J Virol. 1999 Dec;73(12):9741-55 15802963 - Viral Immunol. 2005;18(1):190-6 9060651 - J Virol. 1997 Apr;71(4):2928-33 11704885 - J Neurovirol. 2001 Dec;7(6):528-41 10541871 - Acta Neuropathol. 1999 Nov;98(5):481-7 8527071 - AIDS. 1995 Sep;9(9):1001-8 8972425 - J Neurovirol. 1996 Dec;2(6):423-32 18205925 - Retrovirology. 2008;5:5 7905551 - Lancet. 1994 Feb 12;343(8894):383-5 7546209 - Immunol Today. 1995 Sep;16(9):441-8 16131310 - AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13 11309629 - Nature. 2001 Apr 19;410(6831):988-94 21471230 - J Virol. 2011 Jun;85(12):6024-37 21314481 - AIDS Res Hum Retroviruses. 2011 Sep;27(9):965-7 9614862 - Virology. 1998 May 25;245(1):1-10 12019106 - Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905 15795303 - J Virol. 2005 Apr;79(8):5203-10 1684709 - Viral Immunol. 1991 Summer;4(2):123-31 16775320 - J Virol. 2006 Jul;80(13):6324-32 9359702 - Nat Med. 1997 Nov;3(11):1259-65 18490657 - Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7 15161643 - Am J Pathol. 2004 Jun;164(6):2089-99 8083694 - J Neuropathol Exp Neurol. 1994 Sep;53(5):521-34 20147398 - J Virol. 2010 Apr;84(8):4100-4 7486867 - Ann Neurol. 1995 Nov;38(5):755-62 11024136 - J Virol. 2000 Nov;74(21):10074-80 15331746 - J Virol. 2004 Sep;78(18):10133-48 17015824 - Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15160-5 10469847 - Hum Mol Genet. 1999;8(10):1939-45 15194768 - J Virol. 2004 Jul;78(13):6915-26 18385254 - J Virol. 2008 Jun;82(12):5807-14 9078201 - Lancet. 1997 Mar 8;349(9053):692-5 18672260 - Virology. 2008 Sep 15;379(1):125-34 8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7 12907388 - J Neurovirol. 2003 Aug;9(4):432-41 11304551 - J Exp Med. 2001 Apr 16;193(8):905-15 2429124 - Lancet. 1986 Sep 20;2(8508):660-2 11897037 - AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):353-62 8145918 - Neurology. 1994 Mar;44(3 Pt 1):474-81 17599380 - Virology. 2007 Oct 10;367(1):222-34 9525605 - J Virol. 1998 Apr;72(4):2855-64 22007152 - PLoS Pathog. 2011 Oct;7(10):e1002286 16186242 - J Gen Virol. 2005 Oct;86(Pt 10):2859-69 9396791 - Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 2565516 - Lancet. 1989 May 6;1(8645):983-5 12124446 - J Gen Virol. 2002 Aug;83(Pt 8):1809-29 15832177 - Cell Death Differ. 2005 Aug;12 Suppl 1:878-92 9453248 - AIDS Res Hum Retroviruses. 1998 Jan 1;14(1):25-30 17084877 - Virology. 2007 Mar 30;360(1):105-19 17724130 - J Exp Med. 2007 Sep 3;204(9):2171-85 1513462 - Neurology. 1992 Sep;42(9):1736-9 20570309 - Virology. 2010 Sep 1;404(2):269-78 21795326 - J Virol. 2011 Oct;85(19):9824-33 9420250 - J Virol. 1998 Jan;72(1):488-96 11907256 - J Virol. 2002 Apr;76(8):4138-44 9032338 - J Virol. 1997 Mar;71(3):2059-71 20930940 - Future Virol. 2010 Jul;5(4):435-451 19515785 - J Virol. 2009 Aug;83(16):8208-20 9932303 - Rev Neurol (Paris). 1998 Dec;154(12):816-29 15562411 - Ann Neurol. 2004 Dec;56(6):873-7 15916792 - Virology. 2005 Jul 5;337(2):384-98 8651642 - Ann Neurol. 1996 Jun;39(6):705-11 10691542 - Science. 2000 Jan 28;287(5453):602-4 20425562 - Curr HIV/AIDS Rep. 2010 May;7(2):85-91 16103186 - J Virol. 2005 Sep;79(17):11343-52 20517932 - Ann Neurol. 2010 Jun;67(6):699-714 19619305 - Retrovirology. 2009;6:69 12021361 - J Virol. 2002 Jun;76(12):6277-92 LR Sharer (2864_CR61) 1994; 4 M Alexander (2864_CR3) 2010; 84 A Okoye (2864_CR64) 2007; 204 PJ Peters (2864_CR52) 2008; 5 A Ranki (2864_CR59) 1995; 9 M Salemi (2864_CR47) 2005; 79 A Revilla (2864_CR77) 2011; 27 BF Keele (2864_CR78) 2008; 105 L Gillim-Ross (2864_CR58) 2005; 18 U O'Doherty (2864_CR84) 2000; 74 S Haggerty (2864_CR45) 1991; 4 TC Pierson (2864_CR57) 2002; 76 J Sterjovski (2864_CR74) 2010; 404 SF An (2864_CR40) 1999; 98 M Kaul (2864_CR20) 2005; 12 G Gosztonyi (2864_CR29) 1994; 53 J Isaacman-Beck (2864_CR76) 2009; 83 V Tozzi (2864_CR24) 2005; 21 J Repits (2864_CR16) 2005; 86 L Gray (2864_CR9) 2005; 337 T Fischer-Smith (2864_CR37) 2004; 164 Y Yi (2864_CR55) 2003; 9 JK Wong (2864_CR44) 1997; 71 S Li (2864_CR10) 1999; 73 RL Dunfee (2864_CR67) 2007; 367 M Tersmette (2864_CR8) 1989; 1 PR Gorry (2864_CR51) 2002; 76 M Sharkey (2864_CR56) 2005; 79 G Scarlatti (2864_CR7) 1997; 3 JF Salazar-Gonzalez (2864_CR2) 2009; 206 J Takehisa (2864_CR79) 1998; 245 JD Glass (2864_CR33) 1995; 38 C Ritz (2864_CR87) 2005; 12 H Chen (2864_CR49) 2000; 6 RL Dunfee (2864_CR69) 2009; 6 X Wei (2864_CR82) 2002; 46 PJ Peters (2864_CR12) 2004; 78 YK Donaldson (2864_CR27) 1994; 343 JE Bell (2864_CR26) 1993; 168 C Tornatore (2864_CR62) 1994; 44 T Musich (2864_CR72) 2011; 85 G Schnell (2864_CR73) 2011; 7 J Chang (2864_CR43) 1998; 14 PJ Peters (2864_CR13) 2006; 80 ME Mefford (2864_CR54) 2008; 24 MA Cosenza (2864_CR41) 2002; 12 KJ Liner II (2864_CR22) 2010; 7 KC Williams (2864_CR35) 2001; 193 K Tamura (2864_CR81) 2011; 28 QJ Nottingham (2864_CR86) 2000; 19 S Gartner (2864_CR32) 2000; 287 J Guo (2864_CR85) 2011; 85 Y Liu (2864_CR31) 2000; 6 B Asjo (2864_CR5) 1986; 2 LE Davis (2864_CR25) 1992; 42 ER Thomas (2864_CR53) 2007; 360 RJ Brown (2864_CR71) 2011; 85 DL Tuttle (2864_CR11) 2002; 18 E Seclen (2864_CR17) 2011; 27 RL Dunfee (2864_CR65) 2006; 103 F Gonzalez-Scarano (2864_CR19) 2005; 5 TK Smit (2864_CR48) 2004; 78 Y Saito (2864_CR60) 1994; 44 I Teo (2864_CR28) 1997; 71 JE Bell (2864_CR39) 1998; 154 AB Van't Wout (2864_CR46) 1998; 72 M Westby (2864_CR70) 2007; 81 EJ Platt (2864_CR83) 1998; 72 MJ Duenas-Decamp (2864_CR68) 2009; 83 MJ Duenas-Decamp (2864_CR66) 2008; 82 JD Thompson (2864_CR80) 1997; 25 L Pulliam (2864_CR42) 1997; 349 KA Thompson (2864_CR63) 2004; 56 J Repits (2864_CR15) 2008; 379 T Fischer-Smith (2864_CR36) 2001; 7 K Takahashi (2864_CR38) 1996; 39 RI Connor (2864_CR6) 1994; 68 PR Gorry (2864_CR50) 2001; 75 M Kaul (2864_CR21) 2001; 410 M Carrington (2864_CR1) 1999; 8 HS Nottet (2864_CR30) 1995; 16 JH Lane (2864_CR34) 1996; 2 M Kishko (2864_CR4) 2011; 8 MJ Duenas-Decamp (2864_CR18) 2010; 5 I Karlsson (2864_CR14) 2004; 78 JC McArthur (2864_CR23) 2010; 67 PR Clapham (2864_CR75) 2002; 83 |
References_xml | – volume: 76 start-page: 6277 year: 2002 ident: 2864_CR51 publication-title: J Virol doi: 10.1128/JVI.76.12.6277-6292.2002 contributor: fullname: PR Gorry – volume: 6 start-page: S70 issue: Suppl 1 year: 2000 ident: 2864_CR31 publication-title: J Neurovirol contributor: fullname: Y Liu – volume: 21 start-page: 706 year: 2005 ident: 2864_CR24 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2005.21.706 contributor: fullname: V Tozzi – volume: 2 start-page: 423 year: 1996 ident: 2864_CR34 publication-title: J Neurovirol doi: 10.3109/13550289609146909 contributor: fullname: JH Lane – volume: 6 start-page: 69 year: 2009 ident: 2864_CR69 publication-title: Retrovirology doi: 10.1186/1742-4690-6-69 contributor: fullname: RL Dunfee – volume: 75 start-page: 10073 year: 2001 ident: 2864_CR50 publication-title: J Virol doi: 10.1128/JVI.75.21.10073-10089.2001 contributor: fullname: PR Gorry – volume: 83 start-page: 1809 year: 2002 ident: 2864_CR75 publication-title: J Gen Virol doi: 10.1099/0022-1317-83-8-1809 contributor: fullname: PR Clapham – volume: 80 start-page: 6324 year: 2006 ident: 2864_CR13 publication-title: J Virol doi: 10.1128/JVI.02328-05 contributor: fullname: PJ Peters – volume: 27 start-page: 965 year: 2011 ident: 2864_CR17 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2010.0359 contributor: fullname: E Seclen – volume: 42 start-page: 1736 year: 1992 ident: 2864_CR25 publication-title: Neurology doi: 10.1212/WNL.42.9.1736 contributor: fullname: LE Davis – volume: 44 start-page: 474 year: 1994 ident: 2864_CR60 publication-title: Neurology doi: 10.1212/WNL.44.3_Part_1.474 contributor: fullname: Y Saito – volume: 12 start-page: 878 issue: Suppl 1 year: 2005 ident: 2864_CR20 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401623 contributor: fullname: M Kaul – volume: 67 start-page: 699 year: 2010 ident: 2864_CR23 publication-title: Ann Neurol doi: 10.1001/archneurol.2010.84 contributor: fullname: JC McArthur – volume: 360 start-page: 105 year: 2007 ident: 2864_CR53 publication-title: Virology doi: 10.1016/j.virol.2006.09.036 contributor: fullname: ER Thomas – volume: 85 start-page: 2397 year: 2011 ident: 2864_CR72 publication-title: J Virol doi: 10.1128/JVI.02187-10 contributor: fullname: T Musich – volume: 9 start-page: 1001 year: 1995 ident: 2864_CR59 publication-title: AIDS doi: 10.1097/00002030-199509000-00004 contributor: fullname: A Ranki – volume: 4 start-page: 283 year: 1994 ident: 2864_CR61 publication-title: Adv Neuroimmunol doi: 10.1016/S0960-5428(06)80268-8 contributor: fullname: LR Sharer – volume: 337 start-page: 384 year: 2005 ident: 2864_CR9 publication-title: Virology doi: 10.1016/j.virol.2005.04.034 contributor: fullname: L Gray – volume: 6 start-page: 498 year: 2000 ident: 2864_CR49 publication-title: J Neurovirol doi: 10.3109/13550280009091950 contributor: fullname: H Chen – volume: 1 start-page: 983 year: 1989 ident: 2864_CR8 publication-title: Lancet doi: 10.1016/S0140-6736(89)92628-7 contributor: fullname: M Tersmette – volume: 56 start-page: 873 year: 2004 ident: 2864_CR63 publication-title: Ann Neurol doi: 10.1002/ana.20304 contributor: fullname: KA Thompson – volume: 19 start-page: 389 year: 2000 ident: 2864_CR86 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(20000215)19:3<389::AID-SIM326>3.0.CO;2-J contributor: fullname: QJ Nottingham – volume: 25 start-page: 4876 year: 1997 ident: 2864_CR80 publication-title: Nucleic Acids Res doi: 10.1093/nar/25.24.4876 contributor: fullname: JD Thompson – volume: 379 start-page: 125 year: 2008 ident: 2864_CR15 publication-title: Virology doi: 10.1016/j.virol.2008.06.014 contributor: fullname: J Repits – volume: 7 start-page: 528 year: 2001 ident: 2864_CR36 publication-title: J Neurovirol doi: 10.1080/135502801753248114 contributor: fullname: T Fischer-Smith – volume: 85 start-page: 6024 year: 2011 ident: 2864_CR71 publication-title: J Virol doi: 10.1128/JVI.00131-11 contributor: fullname: RJ Brown – volume: 410 start-page: 988 year: 2001 ident: 2864_CR21 publication-title: Nature doi: 10.1038/35073667 contributor: fullname: M Kaul – volume: 79 start-page: 5203 year: 2005 ident: 2864_CR56 publication-title: J Virol doi: 10.1128/JVI.79.8.5203-5210.2005 contributor: fullname: M Sharkey – volume: 78 start-page: 11807 year: 2004 ident: 2864_CR14 publication-title: J Virol doi: 10.1128/JVI.78.21.11807-11815.2004 contributor: fullname: I Karlsson – volume: 82 start-page: 5807 year: 2008 ident: 2864_CR66 publication-title: J Virol doi: 10.1128/JVI.02585-07 contributor: fullname: MJ Duenas-Decamp – volume: 14 start-page: 25 year: 1998 ident: 2864_CR43 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.1998.14.25 contributor: fullname: J Chang – volume: 18 start-page: 353 year: 2002 ident: 2864_CR11 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/088922202753519133 contributor: fullname: DL Tuttle – volume: 83 start-page: 2575 year: 2009 ident: 2864_CR68 publication-title: J Virol doi: 10.1128/JVI.02133-08 contributor: fullname: MJ Duenas-Decamp – volume: 5 start-page: 417 year: 2010 ident: 2864_CR18 publication-title: Future Virology doi: 10.2217/fvl.10.34 contributor: fullname: MJ Duenas-Decamp – volume: 3 start-page: 1259 year: 1997 ident: 2864_CR7 publication-title: Nat Med doi: 10.1038/nm1197-1259 contributor: fullname: G Scarlatti – volume: 71 start-page: 2928 year: 1997 ident: 2864_CR28 publication-title: J Virol doi: 10.1128/jvi.71.4.2928-2933.1997 contributor: fullname: I Teo – volume: 154 start-page: 816 year: 1998 ident: 2864_CR39 publication-title: Rev Neurol (Paris) contributor: fullname: JE Bell – volume: 4 start-page: 123 year: 1991 ident: 2864_CR45 publication-title: Viral Immunol doi: 10.1089/vim.1991.4.123 contributor: fullname: S Haggerty – volume: 46 start-page: 1896 year: 2002 ident: 2864_CR82 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.46.6.1896-1905.2002 contributor: fullname: X Wei – volume: 12 start-page: 1 year: 2005 ident: 2864_CR87 publication-title: J Stat Softw doi: 10.18637/jss.v012.i05 contributor: fullname: C Ritz – volume: 367 start-page: 222 year: 2007 ident: 2864_CR67 publication-title: Virology doi: 10.1016/j.virol.2007.05.029 contributor: fullname: RL Dunfee – volume: 7 start-page: e1002286 year: 2011 ident: 2864_CR73 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002286 contributor: fullname: G Schnell – volume: 76 start-page: 4138 year: 2002 ident: 2864_CR57 publication-title: J Virol doi: 10.1128/JVI.76.8.4138-4144.2002 contributor: fullname: TC Pierson – volume: 7 start-page: 85 year: 2010 ident: 2864_CR22 publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-010-0042-8 contributor: fullname: KJ Liner II – volume: 5 start-page: 69 year: 2005 ident: 2864_CR19 publication-title: Nat Rev Immunol doi: 10.1038/nri1527 contributor: fullname: F Gonzalez-Scarano – volume: 86 start-page: 2859 year: 2005 ident: 2864_CR16 publication-title: J Gen Virol doi: 10.1099/vir.0.81111-0 contributor: fullname: J Repits – volume: 73 start-page: 9741 year: 1999 ident: 2864_CR10 publication-title: J Virol doi: 10.1128/JVI.73.12.9741-9755.1999 contributor: fullname: S Li – volume: 85 start-page: 9824 year: 2011 ident: 2864_CR85 publication-title: J Virol doi: 10.1128/JVI.05170-11 contributor: fullname: J Guo – volume: 44 start-page: 481 year: 1994 ident: 2864_CR62 publication-title: Neurology doi: 10.1212/WNL.44.3_Part_1.481 contributor: fullname: C Tornatore – volume: 204 start-page: 2171 year: 2007 ident: 2864_CR64 publication-title: J Exp Med doi: 10.1084/jem.20070567 contributor: fullname: A Okoye – volume: 349 start-page: 692 year: 1997 ident: 2864_CR42 publication-title: Lancet doi: 10.1016/S0140-6736(96)10178-1 contributor: fullname: L Pulliam – volume: 38 start-page: 755 year: 1995 ident: 2864_CR33 publication-title: Ann Neurol doi: 10.1002/ana.410380510 contributor: fullname: JD Glass – volume: 5 start-page: 5 year: 2008 ident: 2864_CR52 publication-title: Retrovirology doi: 10.1186/1742-4690-5-5 contributor: fullname: PJ Peters – volume: 27 start-page: 889 year: 2011 ident: 2864_CR77 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2010.0177 contributor: fullname: A Revilla – volume: 84 start-page: 4100 year: 2010 ident: 2864_CR3 publication-title: J Virol doi: 10.1128/JVI.02068-09 contributor: fullname: M Alexander – volume: 9 start-page: 432 year: 2003 ident: 2864_CR55 publication-title: J Neurovirol doi: 10.1080/13550280390218706 contributor: fullname: Y Yi – volume: 206 start-page: 1273 year: 2009 ident: 2864_CR2 publication-title: J Exp Med doi: 10.1084/jem.20090378 contributor: fullname: JF Salazar-Gonzalez – volume: 12 start-page: 442 year: 2002 ident: 2864_CR41 publication-title: Brain Pathol doi: 10.1111/j.1750-3639.2002.tb00461.x contributor: fullname: MA Cosenza – volume: 8 start-page: 67 year: 2011 ident: 2864_CR4 publication-title: Retrovirology doi: 10.1186/1742-4690-8-67 contributor: fullname: M Kishko – volume: 245 start-page: 1 year: 1998 ident: 2864_CR79 publication-title: Virology doi: 10.1006/viro.1998.9141 contributor: fullname: J Takehisa – volume: 404 start-page: 269 year: 2010 ident: 2864_CR74 publication-title: Virology doi: 10.1016/j.virol.2010.05.006 contributor: fullname: J Sterjovski – volume: 24 start-page: 1215 year: 2008 ident: 2864_CR54 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2008.0009 contributor: fullname: ME Mefford – volume: 8 start-page: 1939 year: 1999 ident: 2864_CR1 publication-title: Hum Mol Genet doi: 10.1093/hmg/8.10.1939 contributor: fullname: M Carrington – volume: 164 start-page: 2089 year: 2004 ident: 2864_CR37 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63767-4 contributor: fullname: T Fischer-Smith – volume: 98 start-page: 481 year: 1999 ident: 2864_CR40 publication-title: Acta Neuropathol (Berl) doi: 10.1007/s004010051113 contributor: fullname: SF An – volume: 53 start-page: 521 year: 1994 ident: 2864_CR29 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199409000-00012 contributor: fullname: G Gosztonyi – volume: 79 start-page: 11343 year: 2005 ident: 2864_CR47 publication-title: J Virol doi: 10.1128/JVI.79.17.11343-11352.2005 contributor: fullname: M Salemi – volume: 103 start-page: 15160 year: 2006 ident: 2864_CR65 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0605513103 contributor: fullname: RL Dunfee – volume: 16 start-page: 441 year: 1995 ident: 2864_CR30 publication-title: Immunol Today doi: 10.1016/0167-5699(95)80022-0 contributor: fullname: HS Nottet – volume: 168 start-page: 818 year: 1993 ident: 2864_CR26 publication-title: J Infect Dis doi: 10.1093/infdis/168.4.818 contributor: fullname: JE Bell – volume: 72 start-page: 2855 year: 1998 ident: 2864_CR83 publication-title: J Virol doi: 10.1128/JVI.72.4.2855-2864.1998 contributor: fullname: EJ Platt – volume: 18 start-page: 190 year: 2005 ident: 2864_CR58 publication-title: Viral Immunol doi: 10.1089/vim.2005.18.190 contributor: fullname: L Gillim-Ross – volume: 78 start-page: 10133 year: 2004 ident: 2864_CR48 publication-title: J Virol doi: 10.1128/JVI.78.18.10133-10148.2004 contributor: fullname: TK Smit – volume: 105 start-page: 7552 year: 2008 ident: 2864_CR78 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0802203105 contributor: fullname: BF Keele – volume: 2 start-page: 660 year: 1986 ident: 2864_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(86)90169-8 contributor: fullname: B Asjo – volume: 71 start-page: 2059 year: 1997 ident: 2864_CR44 publication-title: J Virol doi: 10.1128/jvi.71.3.2059-2071.1997 contributor: fullname: JK Wong – volume: 74 start-page: 10074 year: 2000 ident: 2864_CR84 publication-title: J Virol doi: 10.1128/JVI.74.21.10074-10080.2000 contributor: fullname: U O'Doherty – volume: 343 start-page: 383 year: 1994 ident: 2864_CR27 publication-title: Lancet doi: 10.1016/S0140-6736(94)91222-X contributor: fullname: YK Donaldson – volume: 193 start-page: 905 year: 2001 ident: 2864_CR35 publication-title: J Exp Med doi: 10.1084/jem.193.8.905 contributor: fullname: KC Williams – volume: 28 start-page: 2731 year: 2011 ident: 2864_CR81 publication-title: Mol Biol Evol doi: 10.1093/molbev/msr121 contributor: fullname: K Tamura – volume: 72 start-page: 488 year: 1998 ident: 2864_CR46 publication-title: J Virol doi: 10.1128/JVI.72.1.488-496.1998 contributor: fullname: AB Van't Wout – volume: 68 start-page: 4400 year: 1994 ident: 2864_CR6 publication-title: J Virol doi: 10.1128/jvi.68.7.4400-4408.1994 contributor: fullname: RI Connor – volume: 78 start-page: 6915 year: 2004 ident: 2864_CR12 publication-title: J Virol doi: 10.1128/JVI.78.13.6915-6926.2004 contributor: fullname: PJ Peters – volume: 39 start-page: 705 year: 1996 ident: 2864_CR38 publication-title: Ann Neurol doi: 10.1002/ana.410390606 contributor: fullname: K Takahashi – volume: 287 start-page: 602 year: 2000 ident: 2864_CR32 publication-title: Science doi: 10.1126/science.287.5453.602 contributor: fullname: S Gartner – volume: 83 start-page: 8208 year: 2009 ident: 2864_CR76 publication-title: J Virol doi: 10.1128/JVI.00296-09 contributor: fullname: J Isaacman-Beck – volume: 81 start-page: 2359 year: 2007 ident: 2864_CR70 publication-title: J Virol doi: 10.1128/JVI.02006-06 contributor: fullname: M Westby |
SSID | ssj0031808 |
Score | 2.2256863 |
Snippet | Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease... Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5... Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in... Doc number: 20 Abstract Background: Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have... BACKGROUNDTransmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in... BACKGROUND: Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in... Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5... |
SourceID | doaj pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 20 |
SubjectTerms | Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - immunology Acquired Immunodeficiency Syndrome - virology Adaptation, Biological AIDS Brain Brain - immunology Brain - virology CCR5 CD4 Confidence intervals Dementia Disease Entry Envelope Health sciences HIV HIV Envelope Protein gp120 - chemistry HIV Envelope Protein gp120 - genetics HIV-1 - genetics HIV-1 - growth & development HIV-1 - pathogenicity HIV-1 - physiology Human immunodeficiency virus Humans Immune tissue Macrophage-tropism Macrophages - virology Molecular Sequence Data Neurotropism Phylogenetics Selection, Genetic Sequence Analysis, DNA Spleen Statistical methods Studies Viral Tropism |
SummonAdditionalLinks | – databaseName: BioMed Central dbid: RBZ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCIkL4s1CQUZC4hQRP5I43FpEtUWCA6Ko4mL5MVZXotmKTZG48NuZSbKh7h65RfbYsTMPj53xN4y9NtKnqEUsXNKq0E3whVfgUONDG2RpQACdQ376XC9P9MfT6vTfece1P_jC1G_RZZYFbeKKFll6k92SBHFO-_LD71ubi4I55J6baSd4xt321-61_8iWowG1f9c2X1mc8sDJKyvR0T12d3Ih-cHI8_vsBnQP2O0xqeTvh-zP8ZzZtufwaxItvk783FG-rjO0IEWPD6vNOXdd5KuOPMcNRD7AJgGfYrf48vhbIfiXikM3RBbBhl-Mt5WwDfeUXGLsgO6YAO8HHj5iJ0cfvr5fFlOWhcLXZdsXJlY6iTYqXKbQ2KkkfHJYkMo2BaUAiUzUQbdlrKSvk8HiqoGyiUFon2r1mO116w6eMl7RbqiEkJBQl9o530Qvg9NQC4heLNi77OPbixFRwxLGdV6D6maJc5Y4Z1srywV7s-XU3G7YwZh6h_KQGJn1PhSgWNlJIW0wicD6WlPh-JI3bemlASWcbkCqSK8jMbCk5zii4KbrCjhTQsyyB7JFV6lStVmw_YwS9TPk1VtBspN92FBgHRp2ZbRcsFdzNbWkmLcO1pcDjVFa4awW7Mkod_OU0PGSpWqw8yaTyGzOeU23OhvQwxW6LE0tnv0PL56zO-g4SorFE9U-2-t_XsILdM56_3LQy78SsThJ priority: 500 providerName: BioMedCentral – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yIHgR37auEkHwFLbz6O7E2yous4IexJW9hTzZAbdn2ekVvPjbreruaSbswYu3IalkplKPVA2Vrwh5q4XPUfHIXFaSqS545mVyYPHBBFHrxBP-D_nla7s6U5_Pm_O9Vl9YEzbBA08HdxR0RlA1o5vgVPba1F7oJLlTXRIyTtk6b3bJ1OSDQVHHXnQQbguGCeAM18h1e7SMMcOwy3fxzv1ncT2NKP63ffXeZVUWUu7dTCcPyP05pKTHEysPyZ3UPyJ3pyaTvx-TP6dLp9uBpl-zqtFNppcO-3ddgEdhA3xYby-p6yNd9xhJblOkI4xSonMtF12d_mCcfmto6sdKo7SlV9PrJVhDPTabmDbANyeJDqNMn5Czk0_fP67Y3HWB-bY2A9OxUZmbKOHaAucnM_fZwUCuTQ5SJiDSUQVl6tgI32YNw02X6i4Grnxu5VNy0G_69JzQBrOjOoUMhKpWzvkuegFyTC1P0fOKvC8O315NCBsWMa_LGTA_i5KzKDlrrKgr8m4nqWXdmNHo9hblBxRksfs4AHpmZz2z_9Iz-DpUA4t2D78ouPn5AnCKCFr2WBgInRrZ6oocFpRgr6Gc3imSnf3FFgvtwNFLrURF3izTuBJr4Pq0uRlptFQSuKrIs0nvFpYgEBO17GDzrtDIgudypl9fjGjiEkKYruUv_schvST3IKAUWKPHm0NyMFzfpFcQtA3-9WiffwHneEAq priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aEXwRvz2tEkHwKTRfu5v1RapYroI-iJV7C5sve9Dunb2t4It_uzO7ubOh4NuRTHLJzW8mM7nJDCGvjXQpaBFYl7RiuvGOORU7kHjfeslNFBHvIT9_qecn-tOiWuQLt00Oq9zqxFFRh5XHO_IDhE4N_pSW79Y_GVaNwn9XcwmNm-SWgIkR581i53ABXLnJiRqFqQ_A-JYM3UHWMqzvXbxwPysOpjF__3UtfeWYKkMor5xJR_fI3WxM0sOJ-_fJjdg_ILen8pK_H5I_x7satwONvzLI6CrR8w4rd52CLmEDfFhuzmnXB7rs0YbcxEDHBEqR5iguOj_-zgT9WtHYjzFGcUPX07slGEMdlpmYJsDXJpEOIzcfkZOjj98-zFmut8BczduBmVDpJNqg4MACtaeScKmDhsTb5JWKQGSC9rrloZKuTgaaqybyJnihXarVY7LXr_r4lNAK_SIefQJCzXXXuSY46TsdaxGDEzPytvjx7XrKrWEx23XZAyCwyDmLnLOtlXxG3mw5tRs3-jKmvkb5HhlZzD42rC5-2Cya1puEaftaU8H6kjMtd9JEJTrdRKkCfh3CwKLEw4p8lx8uwE4xd5Y9lC0YTZWqzYzsF5Qgqb7s3gLJZk2xsf9wPSOvdt04EqPf-ri6HGmM0gp2NSNPJtzttgQmmOSqgcmbApHFnsuefnk65hFXYLw0tXj2_2U9J3fASJQYdyeqfbI3XFzGF2CIDe7lKG1_AYGhNfM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagCIkL4k2gICMhcQr4lcRBQqggqi1SOSAW9Wb5SVdqs2U3RfTCb2cmyYaG5cAtsseO7fnGnknGM4Q818KloHjIbVIyV5V3uZPRgsT72gumI4_4HfLwUzmbq49HxdEf_6dhAdf_NO0wn9R8dfLy5_eLtyDwbzqB1-UrUKpFjmZeXgPTr5JrQkmFaD9U4x8FgC7TQ9DG7TZ_3XY_mRxSXSz_7R370pE1dae8dD7t3yI3B8WS7vVIuE2uxOYOud6nmry4S34djPluWxp_DICjy0RPLWbxOoZ9JW_hYbE-pbYJdNGgPrmOgXbBlCIdPLro7OBrzunngsam8zeKa3rW32GCNtRhyom-A7x5EmnbcfYeme9_-PJ-lg-5F3JXsrrNdShU4nWQcHjBFigTd8lCQWJ18lJGINJBeVWzUAhXJg3FRRVZFTxXLpXyPtlplk18SGiBNhKLPgGhYspaVwUnvFWx5DE4npHXk8U3Z32cDYORr6c1IIQGOWeQc6Y2gmXkxYZTY7vOrtHlFuU7ZOSk965gufpmBjE1XicM4VfrAsaXnK6ZEzpKblUVhQz4OoSBQTzCiLwdLjHATDGOltkTNShQhSx1RnYnlCC1flq9AZLZgB7d7WC7l1qJjDwbq7ElesI1cXne0WipJMwqIw963I1TAnVMMFlB59UEkZM5T2uaxXEXU1yCIlOV_NF_vPcxuQFao0BHPF7skp12dR6fgGbWuqedyP0GjX06Mg priority: 102 providerName: Scholars Portal |
Title | Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22420378 https://www.proquest.com/docview/1017633842 https://search.proquest.com/docview/1018343690 http://dx.doi.org/10.1186/1742-4690-9-20 https://pubmed.ncbi.nlm.nih.gov/PMC3362761 https://doaj.org/article/c8f8506985ca4fb890b28e31a47e23d0 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1La9swWLQdg13G3vPWBQ0GO7mRJdmWd2tKSzpIKWEdYRdhvdpA44TGHeyy375Psh0qetvFGOmTLfl7m--B0BdBlTM8M2ntOEt5qVWqmK2B43WlKRE2s_4_5OyimF7x74t8sYfyIRcmBO1rtTxqbldHzfImxFZuVno8xImNL2cnDKQuuN_jfbRfMja46J34BRoloq_OmIliDBY3Tb0PmFZAEb72LyglwnxbtSjD_TZSTKF-_2Mp_UBNxSGUD3TS2Qv0vDcm8XG36Zdozzav0NOuveSf1-jv-a7HbYvt757I8NrhVe07d92ALElbuFluV7huDF423obcWoNDASWL-yguPD3_mWZ4nmPbhBgju8WbLm8J1mDl20x0D_DZJha3AZtv0NXZ6Y-Tadr3W0hVQao2FSbnLqsMA4UFYo-5TLkaBhypnGbMApAwXPOKmJyqwgkYzktLSqMzrlzB3qKDZt3Y9wjn3i8iVjsA5ITXtSqNorrmtsisUVmCvkUfX2662hrSV7uOZ4DxpEei9EiUlaQkQV8HTO3WBV9GFI8gJx6R0dPDwPruWvYUJbVwvmxfJXLYn1OiIooKy7Kal5Yy41_nyUB6jocd6bpPXICT-tpZ8phWYDTlrBAJOowggVN1PD0QkuwlxdaH2IGIZ4LTBH3eTfuVPvqtsev7ACMYZ3CqBL3r6G53pIGcE1RGFBmdOZ4Btgp1xHs2-vDfKz-iZ2A_Uh-Sl-WH6KC9u7efwEZr1Qg4c1GO0JPJ6cXlfBT-dMB1xgVc55Nfo8Cz_wDnHkRP |
link.rule.ids | 108,230,315,733,786,790,870,891,2115,2236,12083,21416,24346,24965,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,76167,76168 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagCMEF8SZQwEhInKyuH7vr5YIKokqg7QG1qDdr_Woj0U1otkhc-O3M7DqhViVukT127Mw34xlnPEPIWy1s9Ip71kYlmaqdZVaGFiTeNU4UOvCA95AHh9X0WH05KU_ShdsqhVWudeKgqP3C4R35DkKnAn9KiQ_LnwyrRuG_q6mExk1yS0mpEOf1ycbhArgWOiVq5LraAeNbMHQHWcOwvnf2wv1HdjAN-fuva-krx1QeQnnlTNq7T-4lY5Lujtx_QG6E7iG5PZaX_P2I_Jltatz2NPxKIKOLSM9brNx1BrqE9fBhvjqnbefpvEMbchU8HRIoBZqiuOh09p1x-q2koRtijMKKLsd3SzCGWiwzMU6Ar00C7QduPibHe5-PPk1ZqrfAbFU0PdO-VJE3XsKBBWpPRm5jCw2xaKKTMgCR9sqppvClsFXU0FzWoai948rGSj4hW92iC88ILdEvKoKLQKgK1ba29la4VoWKB2_5hLzPfnyzHHNrGMx2nfcACAxyziDnTGNEMSHv1pzajBt8GV1do_yIjMxmHxoWF6cmiaZxOmLavkaXsL5odVNYoYPkraqDkB6_DmFgUOJhRa5NDxdgp5g7y-yKBoymUlZ6QrYzSpBUl3evgWSSpliZf7iekDebbhyJ0W9dWFwONBrQDbuakKcj7jZbAhNMFLKGyesMkdme855ufjbkEZdgvNQVf_7_Zb0md6ZHB_tmf3b49QW5CwajwBg8Xm6Trf7iMrwEo6y3rwbJ-ws1uDjg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSFdyFQwEhInLJJbCdxuJXCahdoVSGKKi5W_KIrutlVN4sEB347YydZremtt8geJxnl8zyizzMIveZEWs0yHdeW0ZiVSsaSmhp2vKoUSbnJjPsPeXhUTE7Yx9P8dKvVlyftKzkbNefzUTM789zK5VwlA08sOT48oGB1If1Oltom19EN2LOkHBL1zggDUlPe12jMeJFA3E1ilwnGFeDCVQAG15RS11wtOOd-HrgnX8X_sq3eclYhkXLLM43vou-DTh0h5edo3cqR-vNfuccrKX0P3enjVbzfidxH10zzAN3sOlj-foj-TjdtdFtsfvU4xguL57VrDnYG5ipu4WK2muO60XjWuDB1ZTT2NZoM7olieDL9Fmf4S45N42lMZoWX3dEoWIOl62TR3cAdaDG49YB5hE7GH74eTOK-pUMsi7RqY65zZrNKU_CJYFmpzaStYcCmlVWUGhDimilWpTonsrAchvPSpKVWGZO2oLtop1k05gnCuUu9UqMsCLKU1bUstSSqZqbIjJZZhN4GX1Ysu_IdwhXUDmdgbwuHEOEQIipB0gi9GWCwWefTJV5cknznUBLc3Q8sLn6I_vsJxa2rDFjxHN7PSl6lknBDs5qVhlDtHucwJpxRgTdSdX82AjR15bnEPqkgLstpwSO0F0iCMVDh9IBS0RujlWPxgRehnJEIvdpMu5WOYNeYxdrLcMooaBWhxx2oNyoNeyVCZQD3QOdwBkDsS5X3oH165ZUv0a3j92PxeXr06Rm6DdEqcQTALN9DO-3F2jyHiLCVL_ze_weetmNi |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Independent+evolution+of+macrophage-tropism+and+increased+charge+between+HIV-1+R5+envelopes+present+in+brain+and+immune+tissue&rft.jtitle=Retrovirology&rft.au=Gonzalez-Perez%2C+Maria+Paz&rft.au=O%27Connell%2C+Olivia&rft.au=Lin%2C+Rongheng&rft.au=Sullivan%2C+W+Matthew&rft.date=2012-03-15&rft.eissn=1742-4690&rft.volume=9&rft.spage=20&rft.epage=20&rft_id=info:doi/10.1186%2F1742-4690-9-20&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4690&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4690&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4690&client=summon |